Public health campaigns do demonstrably change dementia outcomes, though the effect depends on how the campaign is designed and whether it reaches the people most at risk. A systematic review examining 16 campaign studies involving 34,441 participants, published in 2025, found that awareness campaigns consistently increased knowledge about dementia risk factors across all age groups—from 50% in younger adults to 87.5% in adults aged 24-59 and 81.3% in adults over 60. The real challenge lies not in whether campaigns can work, but in translating that knowledge into lasting behavioral change and implementing programs equitably across different communities.

The evidence is strongest when campaigns combine education with structured support. The BRAIN BOOTCAMP pilot program in Australia, which included 853 older adults with a mean age of 73.3 years, showed a Cohen’s d effect size of 0.59 for decreased dementia risk scores (p<0.001) and a Cohen's d of 0.64 for increased dementia literacy. These aren't small numbers—they represent clinically meaningful changes. Yet even as campaigns demonstrate effectiveness in controlled studies, implementation across entire populations remains patchy, with success varying dramatically by country income level (89% caregiver training availability in high-income countries versus 35% in low-to-middle-income countries, according to WHO tracking).

What the Research Actually Shows About Campaign Effectiveness
How Campaigns Build Knowledge (But Not Always Behavior)
Pilot Programs That Demonstrate Real-World Feasibility
Cost-Effectiveness and the Health Equity Problem
Why Implementation Remains Patchy Despite Strong Evidence
Expert Consensus on What Works (and What Doesn’t)
The Measurement Challenge: Knowing Change When You See It

What the Research Actually Shows About Campaign Effectiveness

The quantified evidence for campaign effectiveness rests on several landmark studies completed between 2023 and 2026. The FINGER (Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability) extended dominance analysis, published in 2023, calculated that prevention campaigns could prevent 1,623 dementia cases per 100,000 people over 30 years, generating an average of 0.043 quality-adjusted life years (QALYs) per person and saving approximately $1,600 per person in healthcare costs. This cost-benefit held even when researchers applied conservative assumptions about real-world implementation.

The 2024 Lancet Standing Commission on Dementia Prevention identified 14 modifiable risk factors across the lifespan—education in early life, hearing loss and high cholesterol in midlife, and social isolation and air pollution in late life—and concluded that 45% of dementia cases worldwide are potentially preventable. This estimate increased from 40% in 2020, reflecting both better evidence and recognition of additional risk factors. However, the commission also noted a critical limitation: campaigns rarely achieve uniform behavioral change. Knowing that hearing loss increases dementia risk by approximately 9% does not automatically lead someone to purchase and consistently wear hearing aids.

How Campaigns Build Knowledge (But Not Always Behavior)

Dementia prevention campaigns appear to work best when they build awareness about specific, actionable risk factors. The Netherlands “We Are the Medicine Ourselves” campaign, which ran from 2018 to 2023 across nine regions in South Limburg and Groningen, targeted 40-75 year-old adults with baseline samples of 4,981 pre-campaign and 3,379 post-campaign participants. The campaign successfully increased knowledge of specific risk and protective factors in exposed individuals and notably improved awareness among low-to-middle-income populations and migrant communities—groups that are often underrepresented in health promotion efforts. Several Dutch municipal services subsequently adopted the campaign model for their own communities.

The knowledge-to-behavior gap, however, remains significant. The Netherlands campaign did not achieve a population-level awareness increase when researchers compared pre- and post-campaign periods across the entire surveyed region. A 2025 systematic review analyzing 16 campaigns noted that while increased dementia knowledge was “robust across all age groups,” the effect on actual behavioral change remained “uncertain,” requiring more high-quality research to understand why people don’t sustain preventive actions once they learn about risk. More than 60% of survey respondents identified at least one barrier to dementia risk-reduction behaviors, and 20.1% specifically cited financial constraints.

Pilot Programs That Demonstrate Real-World Feasibility

Several recent pilot programs have shown that campaigns work better when paired with structured support and individualized coaching. The Brain Health Together program, a 12-week online intervention for older adults reporting cognitive decline, combined weekly group brain health education (1 hour per session) with individual 30-minute coaching. Participants reported increases in exercise frequency, reductions in loneliness, and longer sleep duration. Though the pilot included only seven participants, all completed the program and reported sustained engagement—a meaningful finding when many health interventions see dropout rates above 50%.

The CULTIVAMENTE nudge-based campaign currently underway in Chile uses a pragmatic cluster-randomized trial design with seven senior centers serving adults age 60 and older with cognitive impairment. The intervention includes posters, brochures, and web content delivering nudge-based messaging (simple behavioral prompts designed to make the healthy choice the easy choice). Results show improved self-reported dementia prevention behaviors, better cognitive performance on screening tests, and increased discussions about Alzheimer’s disease and dementia prevention between healthcare providers and patients. The Canadian Consortium on Neurodegeneration in Aging launched Can Thumbs UP in 2019 with a Brain Health PRO program comprising 181 ten-minute educational chapters delivered over 45 weeks in both English and French. The program improved dementia literacy, self-efficacy, and user satisfaction, with preliminary evidence of reductions in modifiable risk factors.

Cost-Effectiveness and the Health Equity Problem

The FINGER model’s calculation of $1,600 savings per person assumes that campaigns and interventions can scale to reach entire populations. But reaching those populations equitably has proven difficult. The WHO Global Action Plan on Dementia, originally set to achieve 75% of countries providing caregiver training by 2025, has fallen substantially short. As of 2025, only 35% of low-to-middle-income countries achieved this target, compared to 89% of high-income countries.

The WHO has extended its timeline to 2031 and acknowledged that global targets “will not be met by 2025.” This disparity matters because dementia burden is highest in low-to-middle-income countries, where 60% of people living with dementia reside as of 2024. The Nottingham Consensus, a January 2026 policy recommendation document developed by 40 multidisciplinary experts after a 2-day workshop and 3-round modified Delphi survey, produced 56 policy recommendations with a critical emphasis on health inequalities. The consensus warned explicitly that unless dementia prevention campaigns are designed to address existing disparities—rather than simply rolled out uniformly—they risk exacerbating inequality by reaching affluent, educated populations while bypassing low-income and migrant communities. One expert consensus recommendation called for “a joined-up approach integrating dementia prevention into broader government policy on smoking, alcohol, pollution, and social inequality reduction,” recognizing that campaigns alone cannot overcome structural barriers.

Why Implementation Remains Patchy Despite Strong Evidence

Financial resource constraints represent the most frequently cited barrier to campaign implementation and behavioral change. Governments in low-to-middle-income countries often lack dedicated budgets for dementia prevention campaigns, and even when campaigns are funded, healthcare system leaders struggle to prioritize dementia prevention against competing demands for cancer screening, maternal health, and infectious disease control. At the individual level, financial barriers appear in surveys with particular frequency among people aged 40-60, the very population most important to reach for prevention of later-life dementia. A second barrier is the limited dementia-capable workforce.

Training community health workers, primary care providers, and healthcare system coordinators to deliver dementia prevention messaging takes time and money. Most clinicians still lack training in dementia risk assessment and prevention counseling, and stigma about dementia remains high in many communities, making patients reluctant to engage even when information is available. The Netherlands campaign documented difficulty reaching individuals aged 40-60 years despite deliberately targeting that age group. These middle-aged adults often face peak work and caregiving demands, have less access to health information, and may not perceive dementia as personally relevant because symptoms lie 20-30 years in the future.

Expert Consensus on What Works (and What Doesn’t)

The 2024 Lancet Standing Commission and the January 2026 Nottingham Consensus both concluded that multidomain interventions—campaigns that address multiple risk factors simultaneously rather than focusing on a single behavior like exercise or diet—show the most promise. The Lancet identified education as a critical protective factor across the lifespan, with studies showing that each year of additional education reduces dementia risk by approximately 7% in older age. However, the commission also noted that current public health campaigns rarely address education equity, meaning they don’t help adults without high school diplomas modify their dementia risk nearly as effectively as they help college-educated individuals.

The WHO’s iSupport program, an evidence-based caregiver training program adapted in over 40 countries across 37 languages, demonstrates that campaigns can scale when they’re integrated into existing health systems and tailored for local contexts. The program improved caregiver knowledge and reduced caregiver burden in studies across high-income and low-to-middle-income settings. Yet even with proven effectiveness and multilingual availability, adoption rates remain below WHO targets, illustrating that clinical evidence alone does not guarantee implementation.

The Measurement Challenge: Knowing Change When You See It

Measuring campaign effectiveness requires clarity about the outcome being tracked. Knowledge outcomes (what people know about dementia risk) show consistent improvements across nearly all campaigns. Risk score improvements (measured using tools like the LIBRA index, which assesses 12 modifiable dementia risk factors) show moderate effect sizes in well-controlled pilot programs like BRAIN BOOTCAMP but smaller real-world effects in population-based campaigns. Behavioral outcomes (actual changes in exercise, sleep, social engagement, hearing aid use) are heterogeneous and inconsistent across programs.

The Geneva Brain Health Services pilot, which delivered a structured 2-session dementia risk assessment to 10 cognitively unimpaired, high-risk patients (mean age 63 years, 70% male) in June 2024, found high participant satisfaction and strong motivation for risk reduction—but the small sample and lack of long-term follow-up prevent conclusions about sustained behavior change. The most honest assessment from 2025-2026 research is that public health campaigns change dementia outcomes in the measurable, intermediate sense—they increase knowledge, reduce risk scores, and improve self-reported engagement. Whether they prevent dementia diagnoses 20-30 years later remains an open question, because the field has not yet followed campaign participants long enough to observe actual dementia incidence reductions. Cost-effectiveness models assume that knowledge changes and risk score reductions will eventually translate to dementia prevention, but the actual link remains theoretical.